Richter Gedeon

Richter Gedeon is a leading European pharmaceutical company with a rich history dating back to 1901, founded by Gedeon Richter in Budapest, Hungary. The company has been at the forefront of pharmaceutical research and development, with a strong focus on women's health and central nervous system disorders, collaborating with renowned institutions such as the University of Oxford and the National Institutes of Health. Over the years, Richter Gedeon has established itself as a major player in the global pharmaceutical industry, with partnerships with companies like Merck & Co., Pfizer, and GlaxoSmithKline. The company's commitment to innovation has earned it recognition from organizations such as the European Federation of Pharmaceutical Industries and Associations and the International Federation of Pharmaceutical Manufacturers & Associations.

● Introduction

Richter Gedeon has a long history of innovation, with a strong focus on research and development, working closely with institutions like the European Medicines Agency and the World Health Organization. The company's product portfolio includes a range of prescription medications, such as Cariprazine, a treatment for schizophrenia and bipolar disorder, developed in collaboration with Allergan and Forest Laboratories. Richter Gedeon has also been involved in the development of hormonal therapies, including Diane-35, a treatment for polycystic ovary syndrome, and Esmya, a treatment for uterine fibroids, with partnerships with companies like Bayer and Novartis. The company's commitment to women's health has led to collaborations with organizations such as the American College of Obstetricians and Gynecologists and the European Society of Human Reproduction and Embryology.

● History

Richter Gedeon was founded in 1901 by Gedeon Richter, a Hungarian pharmacist and entrepreneur, in Budapest, Hungary. The company started as a small pharmacy and quickly grew into a successful pharmaceutical business, with partnerships with companies like Sanofi and AstraZeneca. During World War II, the company played a significant role in the production of medicines and medical supplies for the Hungarian Army and the Red Cross. In the post-war period, Richter Gedeon continued to expand its operations, establishing partnerships with companies like Roche and Eli Lilly and Company. The company has also been involved in various mergers and acquisitions, including the acquisition of Pharmavit, a Romanian pharmaceutical company, and the establishment of partnerships with companies like Teva Pharmaceutical Industries and Mylan.

● Products and Services

Richter Gedeon offers a wide range of pharmaceutical products and services, including prescription medications, over-the-counter medications, and medical devices. The company's product portfolio includes treatments for various therapeutic areas, such as women's health, central nervous system disorders, and oncology, with collaborations with institutions like the National Cancer Institute and the European Organisation for Research and Treatment of Cancer. Richter Gedeon has also developed a range of generic medications, including antibiotics and antivirals, with partnerships with companies like Sandoz and Mylan. The company's services include contract manufacturing and contract research, with collaborations with companies like Lonza and Covance.

● Research and Development

Richter Gedeon has a strong commitment to research and development, with a focus on developing innovative treatments for various diseases and disorders. The company's research and development activities are carried out in collaboration with renowned institutions such as the University of Cambridge, the Massachusetts Institute of Technology, and the Stanford University School of Medicine. Richter Gedeon has also established partnerships with companies like Biogen and Gilead Sciences to develop new treatments for rare diseases and orphan diseases. The company's research and development pipeline includes several clinical trials and preclinical studies, with collaborations with institutions like the National Institutes of Health and the European Medicines Agency.

● Corporate Affairs

Richter Gedeon is a publicly traded company listed on the Budapest Stock Exchange and the Luxembourg Stock Exchange. The company is led by a board of directors and a management team, with Gábor Orbán serving as the company's chief executive officer. Richter Gedeon has established partnerships with various non-governmental organizations and industry associations, including the European Federation of Pharmaceutical Industries and Associations and the International Federation of Pharmaceutical Manufacturers & Associations. The company is also committed to corporate social responsibility, with initiatives focused on environmental sustainability, social responsibility, and philanthropy, with collaborations with organizations like the World Wildlife Fund and the Red Cross.

Category:Pharmaceutical companies